OMA Conference Livestream

Even if you can't attend the Overcoming Obesity 2019 Conference in Boston, you don't have to miss out on the top obesity medicine education offered. Livestream 18 of the sessions from the Fall Obesity Summit online on October 4-6. All you need is an internet connection!

Livestream Registration

Individual

OMA Member: $65
Non-member: $80

Register as an Individual

Group

OMA Member: $97
Non-member: $120

Register as a Group

How to Participate

  1. Register for the livestream as either an individual or a group. Group registrations may only stream the webcast on a single device. We recommend projecting the livestream on a screen for group registrations.
  2. Check your inbox for your confirmation email. This contains a link and unique password to access the livestream at the time of the event.
  3. On October 4-6, use your link and password to log in and watch the conference live!

Please note: You must watch the webcast live. Recordings will not be available without an additional purchase. Individual CME/CE credit for the livestream is available as a separate purchase.

Schedule on Friday, October 4

All times are in Eastern Time.

8:00-9:00 AM - Overcoming Obesity 2019 Keynote Address: Countering Food Industry Influence

Marion Nestle, PhD, MPH

Healthcare providers who work with patients who have excess weight or obesity focus on ways to improve personal dietary choices, but today’s food environment makes it socially acceptable to eat highly caloric “junk” foods everywhere, in large portions, at all times of day. This “obesogenic” environment results from food company imperatives to sell as much food as possible to as many people as possible in order to maximize shareholder value. Food companies promote sales not only through advertising, but also through strategies analogous to those of the tobacco industry’s “playbook”: cast doubt on science linking products to obesity, fund favorable science, blame personal responsibility, defend self-regulation, lobby, and litigate. Overcoming the obesity epidemic requires education about and restrictions on food-industry marketing and playbook practices.

  • Describe how food companies follow the tobacco industry’s “playbook” in promoting unfettered sales of their products.
  • List the primary findings of research on the “funding effect” of industry sponsorship on food and nutrition research.
  • Explain why food industry practices constitute such a powerful barrier to healthy food choices, and what actions should be taken by government and civil society to counter such practices.

9:45-10:45 AM - Key Advances in Obesity Medicine Industry Panel

  • Examine the governmental and institutional challenges associated with obesity treatment.
  • Identify the impact of stigma and bias in government and industry policy on obesity treatment.
  • Effectively advocate for patients with obesity to improve patient care.

11:00-11:45 AM - Brown Fat in Health and Disease

Paul Cohen, MD, PhD

Learn about the basic biology of brown fat, including its bio-energetic and endocrine functions. Explore techniques for imaging and quantifying brown fat in humans. Examine the role of brown fat in regulating body weight and cardiometabolic health, and the potential of brown fat as a therapeutic target.

  • Identify the basic biology of brown fat.
  • Learn how brown fat is detected and quantified.
  • Understand the role of brown fat in regulating body weight and cardiometabolic health.
  • Discover the potential of brown fat as a theraputic target.

11:45 AM-12:30 PM - Update on Endoscopic Procedures

Shelby Sullivan, MD

Learn about endoscopic and non-endoscopic procedures, with an emphasis on newer procedures and their role in obesity management.

  • Discuss new and emerging endoscopic bariatric therapies.
  • Review risks and outcomes data of endoscopic procedures.
  • Discuss the role of endscopic therapies in a comprehensive obesity management plan.
  • Identify who is a candidate for endscopic bariatric procedures.

1:30-2:45 PM - Obesity Treatment in Low-income Patients

Caroline M. Apovian, MD, FACP, FACN, Dipl. ABOM

3:30-4:45 PM - Breaking the Plateau: Case Reviews on Long-term Weight Management

Tonia Vinton, MD, Dipl. ABOM, Dipl. ABIM

Learn how to evaluate and diagnose the issues contributing to a patient's weight loss plateau. Discuss why patients experience plateaus and how to determine if it is a true plateau, identify factors hindering further weight loss, evaluate for mood issues, and formulate a comprehensive plan including medication dose titration or additions.

  • Discuss weight loss plateaus.
  • Conduct a comprehensive evaluation for a weight loss plateau.
  • Establish a plan with the patient on how to break the plateau.

4:45-5:30 PM - The Management and Treatment of Patients with Super Obesity

Devika Umashanker, MD, MS, MBA

"Super obesity" is associated with numerous medical comorbidities that can be incapacitating but are commonly treated with bariatric surgery. Though the growth rate appears to have slowed down since 2005, the prevalence of clinically severe obesity continues to increase. Literature on the medical management of patients with super obesity is limited. This lecture will provide alternative options to surgical weight loss for the treatment of super obesity.

  • Understand the pathophysiology associated with patients with super obesity.
  • Understand the comorbidities associated with patients with super obesity.
  • Explore alternative options to bariatric surgery.

Schedule on Saturday, October 5

All times are in Eastern Time.

8:15-9:15 AM - Overcoming Obesity 2019 Keynote Address: Childhood Obesity and Its Effect Across the Lifespan

William H. Dietz, MD, PhD

Childhood obesity now affects approximately 18% of children and adolescents ages 2-19 in the United States. Risk factors begin in pregnancy, where diabetes, excessive weight gain, and tobacco use have been associated with early childhood obesity; and in infancy, where formula feeding, increased protein intake, the early introduction of complementary feedings, and sugary drink intake increase the risk for obesity. The risk for childhood obesity, its persistence into adulthood, and the emergence of disparities continue to rise throughout childhood and adolescence. Although 50% of adult obesity begins in childhood and adolescence, obesity in young adults ages 20-39 offers a potential double benefit for prevention: successful prevention of obesity in young adults may also prevent obesity in their children. The prevalence of obesity and the limited capacity of healthcare to address the disease burden of obesity in youth emphasizes the need for multisectoral approaches for prevention and care.

  • Understand the risk factors for childhood obesity beginning in pregnancy and continuing into young adulthood.
  • Identify strategies for obesity prevention in early care, education, schools, communities, and clinical settings.

10:00-11:00 AM - Managing Overeating: The Key Intersection between Psychology and Neuroscience

David A. Macklin, MD, CCFP, and Sandy Van, MD, Dipl. ABOM

Explore the neurobiological framework of obesity and overeating, and the evidence-based psychological strategies to manage appetite dysregulation. Growing literature suggests that mindfulness-based strategies for eating behavior are effective and superior to traditional models of behavioral weight management for both weight loss and other related parameters. Learn strategies to incorporate these skills into patient encounters, and learn about available resources for patients outside of the clinical setting.

  • Understand the neurobiological framework of overeating behavior.
  • Learn about the effectiveness of mindfulness-based strategies for intensive behavioral therapy for weight loss.
  • Apply psychological strategies in routine clinical encounters as an adjunct to weight management counselling.

11:00 AM-12:00 PM - Treatment of Eating Disorders and Obesity in the Era of Healthy at Every Size

Nicole Garber, MD

Review the diagnostic criteria and epidemiological information about binge-eating disorder, other specified feeding and eating disorders, night-eating disorder, and unspecified eating disorders that commonly co-occur with obesity. Discuss how mental health and eating disorder professionals treat these disorders, including medication management, therapeutic techniques, and dietary recommendations. Also discuss a common orientation within the eating disorder treatment community: "Healthy at Every Size." Learn how to effectively partner with mental health and eating disorder professionals to effectively treat eating disorders and obesity.

  • Define the diagnostic criteria for eating disorders that commonly co-occur in patients with obesity and understand the prevelance of eating disorders in patients with obesity.
  • Recognize key elements of the treatment plans, including medications, dietary recommendations, and therapeutic interventions, which are used to treat the eating disorder.
  • Become familiar with the philosophy of "healthy at every size," including the three main tenets.

12:00-12:30 PM - Q&A Panel

Nicole Garber, MD; David A. Macklin, MD, CCFP; and Sandy Van, MD, Dipl. ABOM

Ask your questions about the psychology of overeating behaviors and the treatment of eating disorders.

12:30-1:45 PM - Screening and Understanding Rare Genetic Variants Impacting Early-Onset, Severe Obesity

Wendy Chung, MD, PhD

Corporate support for this session is provided by Rhythm Pharmaceuticals.

Rare genetic disorders of obesity are ultra-rare diseases that result from genetic variants of the melanocortin-4 receptor (MC4R) pathway, which is a component of the central melanocortin pathway. Variants in genes comprising this pathway result in impaired MC4R pathway signaling and may lead to insatiable hunger hyperphagia, decreased energy expenditure, and increased body weight. Understanding the phenotypes as well as the underlying causes (e.g. genetic) of the different types of dysfunctional eating may help with clinical decision making. This program will focus on identifying individuals with genetic causes of obesity (such as rare genetic disorders of obesity) through genetic testing.

The presentation will provide a deeper understanding of when to initiative genetic testing in individuals with severe obesity and how to interpret/understand results from genetic screening tests. Because clinicians who see individuals with obesity may not be familiar with interpreting results from genetic tests, Dr. Chung will also be discussing how to navigate around the field of genetics and review rare genetic variants that can influence clinical characteristics of obesity.

1:45-3:00 PM - Cardiovascular Safety of Obesity Medications: Current Evidence and Practical Implications for Clinicians

Eldad Einav, MD, FACC, Dipl. ABOM

Medical treatment of obesity may have many cardiovascular implications, which vary across the lifespan. Cardiovascular safety is especially relevant for treating elderly patients with multiple cardiovascular disease risk factors.

  • Review the major cardiovascular outcomes trials conducted for anti-obesity medications and their conclusions.
  • Identify the obesity medications that may impact cardiovascular risk and know their potential risk determinants.
  • Find ways to manage high cardiovascular risk in patients with obesity requiring pharmacotherapy.

3:45-4:45 PM - Using Meal Replacements in Obesity Treatment: Grade School to Grandparents

Angela Fitch, MD, FACP, FOMA, Dipl. ABOM

Learn how to use meal replacements in weight management and chronic disease treatment across the lifespan, from pediatrics to geriatrics, from obesity medicine specialty practice to primary care.

  • Understand the clinical evidence for meal replacements.
  • Understand the myths surrounding meal replacements, and enhance your awareness of their efficacy in the management of weight and chronic disease.
  • Understand the value of meal replacements in multiple weight management contexts: weight loss, weight loss maintenance, treatment of chronic disease, and treatment of weight regain.

4:45-5:30 PM - Breastfeeding and Obesity: Challenges for Lactation and Weight Loss Considerations in Lactating Women

Carolynn Francavilla Brown, MD, Dipl. ABOM

Lactating women are often neglected. Pregnancy is a major cause of weight gain for women, and many women are excited to lose weight post-partum. During this lecture, discuss safe options for weight loss in lactating women and explore the many challenges to breastfeeding.

  • Understand how obesity causes challenges to breastfeeding.
  • Identify concerns for anti-obesity medications in lactation.
  • Identify safe nutrition guidelines for weight loss during lactation.

Schedule on Sunday, October 6

All times are in Eastern Time.

8:00-9:30 AM - Point-Counterpoint Discussion: How Much Physical Activity Do Patients Really Need?

Karli Burridge, PA-C, MMS

  • Discuss current physical activity recommendations.
  • Examine the evidence for the current physical activity recommendations.
  • Debate the recommendations for specific activity and goals.

9:45-10:45 AM - Epigenetics and the Obesity Epidemic

Mary-Elizabeth Patti, MD, FACP

What is the role of epigenetics in perpetuating the obesity epidemic? Explore epigenetic transmission of the disease of obesity and the implications for developing treatment interventions to reverse the obesity epidemic.

  • Discuss the mechanisms of epigenetic inheritance of obesity and its impact on future generations.
  • Examine the impact of epigenetics on obesity and related diseases and conditions.
  • Analyze how environmental and other factors influence epigenetic transmission of obesity.

10:45 AM-12:00 PM - Complex Cases in Obesity Treatment: Treating Obesity Across the Lifespan

Diana Pallin, MD; Nicholas Pennings, DO, FOMA, Dipl. ABOM; Fatima Cody Stanford, MD, MPH, MPA, FAAP, FACP, FTOS, Dipl. ABOM

  • Analyze complex obesity medicine cases.
  • Recognize unique nutritional, mobility, behavioral, or medication issues in patients with obesity.
  • Develop personalized treatment strategies for complex cases in obesity medicine.